Medical Care

Global EZH2 Inhibitor Market Research Report 2025

The global market for EZH2 Inhibitor was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for EZH2 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for EZH2 Inhibitor is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for EZH2 Inhibitor in Epithelioidsarcoma is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of EZH2 Inhibitor include Epizyme, Inc., GSK, Hengrui Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for EZH2 Inhibitor, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding EZH2 Inhibitor.
The EZH2 Inhibitor market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global EZH2 Inhibitor market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the EZH2 Inhibitor companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Epizyme, Inc.
GSK
Hengrui Pharmaceuticals
Segment by Type
Tablet
Other
Segment by Application
Epithelioidsarcoma
Lymphoma
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EZH2 Inhibitor company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global EZH2 Inhibitor Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Other
1.3 Market by Application
1.3.1 Global EZH2 Inhibitor Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Epithelioidsarcoma
1.3.3 Lymphoma
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global EZH2 Inhibitor Market Perspective (2020-2031)
2.2 Global EZH2 Inhibitor Growth Trends by Region
2.2.1 Global EZH2 Inhibitor Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 EZH2 Inhibitor Historic Market Size by Region (2020-2025)
2.2.3 EZH2 Inhibitor Forecasted Market Size by Region (2026-2031)
2.3 EZH2 Inhibitor Market Dynamics
2.3.1 EZH2 Inhibitor Industry Trends
2.3.2 EZH2 Inhibitor Market Drivers
2.3.3 EZH2 Inhibitor Market Challenges
2.3.4 EZH2 Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top EZH2 Inhibitor Players by Revenue
3.1.1 Global Top EZH2 Inhibitor Players by Revenue (2020-2025)
3.1.2 Global EZH2 Inhibitor Revenue Market Share by Players (2020-2025)
3.2 Global EZH2 Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by EZH2 Inhibitor Revenue
3.4 Global EZH2 Inhibitor Market Concentration Ratio
3.4.1 Global EZH2 Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by EZH2 Inhibitor Revenue in 2024
3.5 Global Key Players of EZH2 Inhibitor Head office and Area Served
3.6 Global Key Players of EZH2 Inhibitor, Product and Application
3.7 Global Key Players of EZH2 Inhibitor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 EZH2 Inhibitor Breakdown Data by Type
4.1 Global EZH2 Inhibitor Historic Market Size by Type (2020-2025)
4.2 Global EZH2 Inhibitor Forecasted Market Size by Type (2026-2031)
5 EZH2 Inhibitor Breakdown Data by Application
5.1 Global EZH2 Inhibitor Historic Market Size by Application (2020-2025)
5.2 Global EZH2 Inhibitor Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America EZH2 Inhibitor Market Size (2020-2031)
6.2 North America EZH2 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America EZH2 Inhibitor Market Size by Country (2020-2025)
6.4 North America EZH2 Inhibitor Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe EZH2 Inhibitor Market Size (2020-2031)
7.2 Europe EZH2 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe EZH2 Inhibitor Market Size by Country (2020-2025)
7.4 Europe EZH2 Inhibitor Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific EZH2 Inhibitor Market Size (2020-2031)
8.2 Asia-Pacific EZH2 Inhibitor Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific EZH2 Inhibitor Market Size by Region (2020-2025)
8.4 Asia-Pacific EZH2 Inhibitor Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America EZH2 Inhibitor Market Size (2020-2031)
9.2 Latin America EZH2 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America EZH2 Inhibitor Market Size by Country (2020-2025)
9.4 Latin America EZH2 Inhibitor Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa EZH2 Inhibitor Market Size (2020-2031)
10.2 Middle East & Africa EZH2 Inhibitor Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa EZH2 Inhibitor Market Size by Country (2020-2025)
10.4 Middle East & Africa EZH2 Inhibitor Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Epizyme, Inc.
11.1.1 Epizyme, Inc. Company Details
11.1.2 Epizyme, Inc. Business Overview
11.1.3 Epizyme, Inc. EZH2 Inhibitor Introduction
11.1.4 Epizyme, Inc. Revenue in EZH2 Inhibitor Business (2020-2025)
11.1.5 Epizyme, Inc. Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK EZH2 Inhibitor Introduction
11.2.4 GSK Revenue in EZH2 Inhibitor Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Hengrui Pharmaceuticals
11.3.1 Hengrui Pharmaceuticals Company Details
11.3.2 Hengrui Pharmaceuticals Business Overview
11.3.3 Hengrui Pharmaceuticals EZH2 Inhibitor Introduction
11.3.4 Hengrui Pharmaceuticals Revenue in EZH2 Inhibitor Business (2020-2025)
11.3.5 Hengrui Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global EZH2 Inhibitor Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tablet
Table 3. Key Players of Other
Table 4. Global EZH2 Inhibitor Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global EZH2 Inhibitor Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global EZH2 Inhibitor Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global EZH2 Inhibitor Market Share by Region (2020-2025)
Table 8. Global EZH2 Inhibitor Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global EZH2 Inhibitor Market Share by Region (2026-2031)
Table 10. EZH2 Inhibitor Market Trends
Table 11. EZH2 Inhibitor Market Drivers
Table 12. EZH2 Inhibitor Market Challenges
Table 13. EZH2 Inhibitor Market Restraints
Table 14. Global EZH2 Inhibitor Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global EZH2 Inhibitor Market Share by Players (2020-2025)
Table 16. Global Top EZH2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EZH2 Inhibitor as of 2024)
Table 17. Ranking of Global Top EZH2 Inhibitor Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by EZH2 Inhibitor Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of EZH2 Inhibitor, Headquarters and Area Served
Table 20. Global Key Players of EZH2 Inhibitor, Product and Application
Table 21. Global Key Players of EZH2 Inhibitor, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global EZH2 Inhibitor Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global EZH2 Inhibitor Revenue Market Share by Type (2020-2025)
Table 25. Global EZH2 Inhibitor Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global EZH2 Inhibitor Revenue Market Share by Type (2026-2031)
Table 27. Global EZH2 Inhibitor Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global EZH2 Inhibitor Revenue Market Share by Application (2020-2025)
Table 29. Global EZH2 Inhibitor Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global EZH2 Inhibitor Revenue Market Share by Application (2026-2031)
Table 31. North America EZH2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America EZH2 Inhibitor Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America EZH2 Inhibitor Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe EZH2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe EZH2 Inhibitor Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe EZH2 Inhibitor Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific EZH2 Inhibitor Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific EZH2 Inhibitor Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific EZH2 Inhibitor Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America EZH2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America EZH2 Inhibitor Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America EZH2 Inhibitor Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa EZH2 Inhibitor Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa EZH2 Inhibitor Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa EZH2 Inhibitor Market Size by Country (2026-2031) & (US$ Million)
Table 46. Epizyme, Inc. Company Details
Table 47. Epizyme, Inc. Business Overview
Table 48. Epizyme, Inc. EZH2 Inhibitor Product
Table 49. Epizyme, Inc. Revenue in EZH2 Inhibitor Business (2020-2025) & (US$ Million)
Table 50. Epizyme, Inc. Recent Development
Table 51. GSK Company Details
Table 52. GSK Business Overview
Table 53. GSK EZH2 Inhibitor Product
Table 54. GSK Revenue in EZH2 Inhibitor Business (2020-2025) & (US$ Million)
Table 55. GSK Recent Development
Table 56. Hengrui Pharmaceuticals Company Details
Table 57. Hengrui Pharmaceuticals Business Overview
Table 58. Hengrui Pharmaceuticals EZH2 Inhibitor Product
Table 59. Hengrui Pharmaceuticals Revenue in EZH2 Inhibitor Business (2020-2025) & (US$ Million)
Table 60. Hengrui Pharmaceuticals Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report


List of Figures
Figure 1. EZH2 Inhibitor Picture
Figure 2. Global EZH2 Inhibitor Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global EZH2 Inhibitor Market Share by Type: 2024 VS 2031
Figure 4. Tablet Features
Figure 5. Other Features
Figure 6. Global EZH2 Inhibitor Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global EZH2 Inhibitor Market Share by Application: 2024 VS 2031
Figure 8. Epithelioidsarcoma Case Studies
Figure 9. Lymphoma Case Studies
Figure 10. Other Case Studies
Figure 11. EZH2 Inhibitor Report Years Considered
Figure 12. Global EZH2 Inhibitor Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global EZH2 Inhibitor Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global EZH2 Inhibitor Market Share by Region: 2024 VS 2031
Figure 15. Global EZH2 Inhibitor Market Share by Players in 2024
Figure 16. Global Top EZH2 Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EZH2 Inhibitor as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by EZH2 Inhibitor Revenue in 2024
Figure 18. North America EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America EZH2 Inhibitor Market Share by Country (2020-2031)
Figure 20. United States EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe EZH2 Inhibitor Market Share by Country (2020-2031)
Figure 24. Germany EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific EZH2 Inhibitor Market Share by Region (2020-2031)
Figure 32. China EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America EZH2 Inhibitor Market Share by Country (2020-2031)
Figure 40. Mexico EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa EZH2 Inhibitor Market Share by Country (2020-2031)
Figure 44. Turkey EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE EZH2 Inhibitor Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Epizyme, Inc. Revenue Growth Rate in EZH2 Inhibitor Business (2020-2025)
Figure 48. GSK Revenue Growth Rate in EZH2 Inhibitor Business (2020-2025)
Figure 49. Hengrui Pharmaceuticals Revenue Growth Rate in EZH2 Inhibitor Business (2020-2025)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies